Skip to content

Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke

Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04949334
Enrollment
144
Registered
2021-07-02
Start date
2021-09-23
Completion date
2023-07-15
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Ischemic

Keywords

Stroke, Respiratory muscle training, Respiratory function

Brief summary

After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.

Detailed description

After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The worsening of the respiratory function is weakened and lung function declines, leading to dysfunction of expectoration and swallowing, and increasing the incidence of pneumonia after stroke. In addition, it will also lead to a decline in activity ability, which in turn affects the quality of life. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.

Interventions

DEVICEDofin Breathing Strength Builder

If the patient's condition is stable, respiratory muscle training will be performed under Dofin Breathing Strength Builder 7 days after stroke. The patient will receive respiratory muscle training by repetition of 30 times, two courses per day, x 7 days, for three weeks. The initial load was set at 30% of the participants' maximal baseline strength and increased weekly at intervals of 2 cmH2O.

Sponsors

Taipei Medical University Shuang Ho Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Ischemic stroke diagnosed by MRI 2. Age over 20 years old 3. No worsening of stroke or second stroke this time

Exclusion criteria

1. Unable to understand instructions normally, or communication difficulties 2. Patients with endotracheal tube or tracheostomy 3. Angina in recent 3 months, myocardial infarction, heart failure 4. Patients with asthma or chronic obstructive pulmonary disease, spontaneous pneumothorax, and ongoing pneumonia 5. Patients with untreated hernias 6. Pregnant 7. Ongoing fever (body temperature\>38.5°C) 8. Poor hypertension control (higher than 170/100 mmHg three days before intervention) 9. Patients who have had cerebral hemorrhage or aneurysm

Design outcomes

Primary

MeasureTime frameDescription
Respiratory muscle function-1.1BaselineMEP (maximal expiratory pressure)
Respiratory muscle function-1.2Within one week after trainingMEP (maximal expiratory pressure)
Respiratory muscle function-1.3Twelve weeks after trainingMEP (maximal expiratory pressure)
Respiratory muscle function-2.1BaselineMIP (maximal inspiratory pressure)
Respiratory muscle function-2.2Within one week after trainingMIP (maximal inspiratory pressure)
Respiratory muscle function-2.3Twelve weeks after trainingMIP (maximal inspiratory pressure)

Secondary

MeasureTime frameDescription
Body composition.1BaselineBody composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Body composition.2Within one week after trainingBody composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Body composition.3Twelve weeks after trainingBody composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Life quality.1BaselineQuality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Dyspnea.1BaselineDyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Life quality.3Twelve weeks after trainingQuality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Swallowing.1BaselineSwallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Swallowing.2Within one week after trainingSwallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Swallowing.3Twelve weeks after trainingSwallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Life quality.2Within one week after trainingQuality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Dyspnea.2Within one week after trainingDyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Dyspnea.3Twelve weeks after trainingDyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Exercise tolerance.1BaselineExercise tolerance assessed by six-minute walk test (6MWT).
Exercise tolerance.2Within one week after trainingExercise tolerance assessed by six-minute walk test (6MWT).
Exercise tolerance.3Twelve weeks after trainingExercise tolerance assessed by six-minute walk test (6MWT).

Countries

Taiwan

Contacts

Primary ContactRuey Chen, PhD
18622@s.tmu.edu.tw886-2-2249088
Backup ContactTzu-Ang Chen, MD
b101103035@tmu.edu.tw886-915855505

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026